Minimal change nephrotic syndrome in a patient with strongyloidiasis
Authors:
- 12 March 2010
- journal article
- case report
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 14 (4) , 367-371
Abstract
Strongyloidiasis, a chronic infection caused by the intestinal parasite Strongyloides stercoralis, is prevalent in the Nansei Islands of Japan. Here, we report our findings on a case of strongyloidiasis complicated with steroid-resistant minimal change nephrotic syndrome in a 69-year-old male resident of Fukuoka Prefecture who had lived in Yakushima, one of the Nansei Islands, until age 15. In October 2006, he developed proteinuria and edema, and was diagnosed with minimal change nephrotic syndrome on the basis of the renal biopsy findings. Following treatment with prednisolone, the level of proteinuria decreased to 0.29 g/day by day 35. However, 5 days later (day 40), the patient developed persistent watery diarrhea and vomiting, leading to dehydration and malnutrition. Pneumonia and bacterial meningitis subsequently developed (day 146); filarial (infectious-type) and rhabditiform (noninfectious-type) S. stercoralis larvae were detected for the first time in the patient’s sputum, gastric juice, feces, and urine. Although treatment with ivermectin was started immediately and the parasitosis responded to the treatment, the patient died of sepsis. Consequently, although strongyloidiasis is a rare infection except in endemic regions, it is essential to consider the possibility of this disease and begin treatment early for patients who have lived in endemic areas and who complain of unexplained diarrhea during steroid-induced or other immunosuppression.Keywords
This publication has 26 references indexed in Scilit:
- Severe strongyloidiasis in corticosteroid-treated patients: Case series and literature reviewJournal of Infection, 2007
- Minimal change nephrotic syndrome in association with strongyloidiasisClinical Nephrology, 2006
- Disseminated strongyloidiasis: a retrospective study of clinical course and outcomeEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Strongyloides Hyperinfection and HypogammaglobulinemiaClinical and Vaccine Immunology, 2005
- Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasisExpert Opinion on Pharmacotherapy, 2004
- Pathology of Renal Diseases in the TropicsSeminars in Nephrology, 2003
- Strongyloidiasis Associated with Nephrotic Syndrome.Internal Medicine, 1998
- Plasma histamine in patients with chronic renal failure and nephrotic syndrome.Journal of Clinical Pathology, 1991
- Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndromeArchives of internal medicine (1960), 1990
- STEROID THERAPY AND STRONGYLOIDIASISThe Lancet, 1966